Intraocular Pressure Changes After Intravitreal Fluocinolone Acetonide Implant: Results from Four European Countries

INTRODUCTION: The 0.19 mg fluocinolone acetonide (FAc) intravitreal implant delivers a continuous intravitreal corticosteroid dose for the treatment of refractory diabetic macular oedema (DMO). The aim of this study was to assess the impact of an FAc intravitreal implant on intraocular pressure (IOP...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebrize, Sarah, Arnould, Louis, Bourredjem, Abderrahmane, Busch, Catharina, Rehak, Matus, Massin, Pascale, Barbosa-Breda, Joao, Lupidi, Marco, Mariotti, Cesare, Hamza, Mahmoud, Grise-Dulac, Alice, Gabrielle, Pierre-Henry, Baillif, Stephanie, Creuzot-Garcher, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114211/
https://www.ncbi.nlm.nih.gov/pubmed/35426623
http://dx.doi.org/10.1007/s40123-022-00504-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114211/
https://www.ncbi.nlm.nih.gov/pubmed/35426623
http://dx.doi.org/10.1007/s40123-022-00504-z

Ejemplares similares